Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
Nonfiction, Health & Well Being, Medical, Specialties, Rheumatology
| Author: | Jack Cush, Kathryn H. Dao | ISBN: | 9781455750597 |
| Publisher: | Elsevier Health Sciences | Publication: | November 15, 2012 |
| Imprint: | Saunders | Language: | English |
| Author: | Jack Cush, Kathryn H. Dao |
| ISBN: | 9781455750597 |
| Publisher: | Elsevier Health Sciences |
| Publication: | November 15, 2012 |
| Imprint: | Saunders |
| Language: | English |
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
